Systemically circulating bacterial extracellular vesicles: origin, fate, and function
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2022/03/01
-
Journal
-
Indian UGC (journal)
-
Refrences15
-
Citations19
-
An Hendrix ORCID (unauthenticated)
-
Olivier De Wever
Cite
Hendrix, An, and Olivier De Wever. “Systemically Circulating Bacterial Extracellular Vesicles: Origin, Fate, and Function”. Trends in Microbiology, vol. 30, no. 3, 2022, pp. 213-6, https://doi.org/10.1016/j.tim.2021.12.012.
Hendrix, A., & De Wever, O. (2022). Systemically circulating bacterial extracellular vesicles: origin, fate, and function. Trends in Microbiology, 30(3), 213-216. https://doi.org/10.1016/j.tim.2021.12.012
Hendrix, An, and Olivier De Wever. “Systemically Circulating Bacterial Extracellular Vesicles: Origin, Fate, and Function”. Trends in Microbiology 30, no. 3 (2022): 213-16. https://doi.org/10.1016/j.tim.2021.12.012.
Hendrix A, De Wever O. Systemically circulating bacterial extracellular vesicles: origin, fate, and function. Trends in Microbiology. 2022;30(3):213-6.
Journal Categories
Science
Biology (General)
Science
Microbiology
You May Also Like
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables | Nature Protocols |
| 21 | 2021 |
| Microbiome analyses of blood and tissues suggest cancer diagnostic approach | Nature |
| 593 | 2020 |
The human tumor microbiome is composed of tumor type–specific intracellular bacteria | Science |
| 989 | 2020 |
| Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction | Gut |
| 157 | 2020 |
| Emerging role of bacterial extracellular vesicles in cancer | Oncogene |
| 85 | 2020 |
Refrences Analysis
The category
Science: Chemistry: Organic chemistry: Biochemistry 6
is the most frequently represented among the references in this article. It primarily includes studies from Gut and Nature Protocols. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics | Acta Biomaterialia |
| 2024 | |
| Multi-prospects of bacterial extracellular vesicles in immune modulation, inflammation regulation, and periodontitis treatment | Nano Today |
| 2024 | |
| Extracellular vesicles in the pathogenesis of Campylobacter jejuni | SSRN Electronic Journal | 2024 | ||
Sub-MIC Antibiotics Modulate Productions of Outer Membrane Vesicles in Tigecycline-Resistant Escherichia coli | Antibiotics |
| 2024 | |
| A bacterially engineered macrophage sponge as a neutralization decoy to treat bacterial infection | Matter | 3 | 2023 |
Citations Analysis
The category
Science: Microbiology 4
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies and was published in 2022. The most recent citation comes from a 2024 study titled Unveiling clinical applications of bacterial extracellular vesicles as natural nanomaterials in disease diagnosis and therapeutics. This article reached its peak citation in 2023, with 12 citations. It has been cited in 18 different journals, 33% of which are open access. Among related journals, the Pharmaceutics cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.